Deutsche Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Deutsche Bank’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-68,753	Closed	-$11.9M	–	5659
2015 Q1	$11.9M	Sell	68,753 -305,949	-82%	-$44.9M	0.01%	1217
2014 Q4	$43.1M	Buy	374,702 +169,001	+82%	+$20.5M	0.03%	632
2014 Q3	$32.1M	Sell	205,701 -1,798	-0.9%	-$261K	0.02%	727
2014 Q2	$25.6M	Buy	207,499 +7,164	+4%	+$792K	0.02%	804
2014 Q1	$20.8M	Sell	200,335 -55,244	-22%	-$5.66M	0.01%	903
2013 Q4	$23M	Buy	255,579 +100,935	+65%	+$8.05M	0.02%	835
2013 Q3	$10.3M	Sell	154,644 -80,132	-34%	-$5.52M	0.01%	1305
2013 Q2	$15.5M	Buy	+234,776	New	+$13.4M	0.01%	981

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Deutsche Bank's SLXP Position: Q2 2015 in Review

Deutsche Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 68,753 shares — an estimated $11.9M sold.

Deutsche Bank first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $43.1M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Deutsche Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Deutsche Bank sold 68,753 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $11.9M.
Deutsche Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Deutsche Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $43.1M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Deutsche Bank's 13F filing for Q2 2015, filed 12 Aug 2015.